Scott A. Laurie
Ottawa Hospital(CA)Ottawa Hospital(CA)Ottawa Regional Cancer Foundation(CA)Ottawa Hospital Research InstituteOttawa University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial(2016)1,159 cited
- → Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study(2016)952 cited
- → Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial(2017)517 cited
- → American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer(2006)504 cited
- → Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer(2016)493 cited
- → Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer